nodes	percent_of_prediction	percent_of_DWPC	metapath
Didanosine—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.151	0.276	CbGbCtD
Didanosine—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.134	0.246	CbGbCtD
Didanosine—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.114	0.209	CbGbCtD
Didanosine—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0772	0.141	CbGbCtD
Didanosine—SLC22A6—Losartan—type 2 diabetes mellitus	0.0706	0.129	CbGbCtD
Didanosine—PNP—Purine catabolism—CAT—type 2 diabetes mellitus	0.00722	0.0733	CbGpPWpGaD
Didanosine—PNP—Purine catabolism—GPX1—type 2 diabetes mellitus	0.00653	0.0663	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—AK1—type 2 diabetes mellitus	0.00465	0.0472	CbGpPWpGaD
Didanosine—PNP—kidney—type 2 diabetes mellitus	0.00406	0.141	CbGeAlD
Didanosine—SLC29A2—cardiovascular system—type 2 diabetes mellitus	0.00311	0.108	CbGeAlD
Didanosine—PNP—Purine metabolism—CAT—type 2 diabetes mellitus	0.00278	0.0282	CbGpPWpGaD
Didanosine—SLC29A2—adipose tissue—type 2 diabetes mellitus	0.00275	0.0951	CbGeAlD
Didanosine—PNP—liver—type 2 diabetes mellitus	0.00256	0.0888	CbGeAlD
Didanosine—PNP—Purine metabolism—GPX1—type 2 diabetes mellitus	0.00251	0.0255	CbGpPWpGaD
Didanosine—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00215	0.0745	CbGeAlD
Didanosine—SLC29A1—islet of Langerhans—type 2 diabetes mellitus	0.00214	0.0739	CbGeAlD
Didanosine—SLC29A2—liver—type 2 diabetes mellitus	0.00193	0.0667	CbGeAlD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—AVP—type 2 diabetes mellitus	0.00189	0.0192	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00186	0.0189	CbGpPWpGaD
Didanosine—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00184	0.0638	CbGeAlD
Didanosine—SLC29A1—cardiovascular system—type 2 diabetes mellitus	0.00154	0.0535	CbGeAlD
Didanosine—SLC29A1—kidney—type 2 diabetes mellitus	0.00151	0.0523	CbGeAlD
Didanosine—SLC29A1—pancreas—type 2 diabetes mellitus	0.0015	0.052	CbGeAlD
Didanosine—SLC29A1—cortex of kidney—type 2 diabetes mellitus	0.00147	0.051	CbGeAlD
Didanosine—PNP—Nucleotide metabolism—CAT—type 2 diabetes mellitus	0.0014	0.0142	CbGpPWpGaD
Didanosine—SLC29A1—adipose tissue—type 2 diabetes mellitus	0.00136	0.0472	CbGeAlD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—AVP—type 2 diabetes mellitus	0.00131	0.0133	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.00129	0.0131	CbGpPWpGaD
Didanosine—PNP—Nucleotide metabolism—GPX1—type 2 diabetes mellitus	0.00126	0.0128	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.00124	0.0126	CbGpPWpGaD
Didanosine—SLC29A1—Fluoropyrimidine Activity—MTHFR—type 2 diabetes mellitus	0.00122	0.0124	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.0012	0.0122	CbGpPWpGaD
Didanosine—SLC29A2—Transport of vitamins, nucleosides, and related molecules—ALB—type 2 diabetes mellitus	0.00114	0.0116	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000976	0.00992	CbGpPWpGaD
Didanosine—SLC29A1—liver—type 2 diabetes mellitus	0.000955	0.0331	CbGeAlD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000944	0.0096	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.00094	0.00955	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.00086	0.00874	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00083	0.00844	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000799	0.00812	CbGpPWpGaD
Didanosine—SLC29A1—Transport of vitamins, nucleosides, and related molecules—ALB—type 2 diabetes mellitus	0.000793	0.00806	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000772	0.00784	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A4—type 2 diabetes mellitus	0.000756	0.00768	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000677	0.00688	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000655	0.00665	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000651	0.00662	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000642	0.00653	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.00063	0.0064	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000613	0.00623	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000609	0.00618	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000609	0.00618	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000598	0.00608	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A8—type 2 diabetes mellitus	0.000595	0.00605	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A2—type 2 diabetes mellitus	0.000573	0.00582	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000557	0.00566	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000554	0.00563	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000535	0.00544	CbGpPWpGaD
Didanosine—PNP—Metabolism—BHMT—type 2 diabetes mellitus	0.000534	0.00543	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC26A9—type 2 diabetes mellitus	0.000515	0.00523	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000497	0.00505	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000496	0.00504	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000496	0.00504	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000478	0.00485	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000478	0.00485	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000477	0.00485	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000469	0.00477	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGDS—type 2 diabetes mellitus	0.000467	0.00474	CbGpPWpGaD
Didanosine—PNP—Metabolism—AANAT—type 2 diabetes mellitus	0.000467	0.00474	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000445	0.00452	CbGpPWpGaD
Didanosine—PNP—Metabolism—CDO1—type 2 diabetes mellitus	0.000442	0.0045	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPD2—type 2 diabetes mellitus	0.000442	0.0045	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000437	0.00444	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000434	0.00441	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.000425	0.00432	CbGpPWpGaD
Didanosine—PNP—Metabolism—AK1—type 2 diabetes mellitus	0.000422	0.00429	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000422	0.00429	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000422	0.00429	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000415	0.00422	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000406	0.00413	CbGpPWpGaD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000405	0.00412	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000392	0.00399	CbGpPWpGaD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—type 2 diabetes mellitus	0.000392	0.00398	CbGpPWpGaD
Didanosine—PNP—Metabolism—MAT1A—type 2 diabetes mellitus	0.000389	0.00396	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC5A4—type 2 diabetes mellitus	0.000389	0.00396	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000386	0.00392	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPP1R3C—type 2 diabetes mellitus	0.000376	0.00382	CbGpPWpGaD
Didanosine—PNP—Metabolism—ENPP1—type 2 diabetes mellitus	0.000376	0.00382	CbGpPWpGaD
Didanosine—PNP—Metabolism—HBA2—type 2 diabetes mellitus	0.000376	0.00382	CbGpPWpGaD
Didanosine—PNP—Metabolism—G6PC—type 2 diabetes mellitus	0.000376	0.00382	CbGpPWpGaD
Didanosine—PNP—Metabolism—ND1—type 2 diabetes mellitus	0.000376	0.00382	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000376	0.00382	CbGpPWpGaD
Didanosine—PNP—Metabolism—GCGR—type 2 diabetes mellitus	0.000364	0.0037	CbGpPWpGaD
Didanosine—Headache—Repaglinide—type 2 diabetes mellitus	0.000353	0.00108	CcSEcCtD
Didanosine—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000352	0.00108	CcSEcCtD
Didanosine—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000351	0.00108	CcSEcCtD
Didanosine—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.00035	0.00108	CcSEcCtD
Didanosine—Dyspepsia—Bromocriptine—type 2 diabetes mellitus	0.000345	0.00106	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000345	0.0035	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYTB—type 2 diabetes mellitus	0.000344	0.0035	CbGpPWpGaD
Didanosine—PNP—Metabolism—OXCT1—type 2 diabetes mellitus	0.000344	0.0035	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000344	0.00349	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000344	0.00349	CbGpPWpGaD
Didanosine—Abdominal pain—Glimepiride—type 2 diabetes mellitus	0.000344	0.00106	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000344	0.00349	CbGpPWpGaD
Didanosine—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000343	0.00105	CcSEcCtD
Didanosine—Abdominal pain—Sitagliptin—type 2 diabetes mellitus	0.000343	0.00105	CcSEcCtD
Didanosine—Anorexia—Glyburide—type 2 diabetes mellitus	0.000342	0.00105	CcSEcCtD
Didanosine—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000341	0.00105	CcSEcCtD
Didanosine—Chills—Metformin—type 2 diabetes mellitus	0.00034	0.00105	CcSEcCtD
Didanosine—Hepatitis—Losartan—type 2 diabetes mellitus	0.000337	0.00103	CcSEcCtD
Didanosine—Myalgia—Gliclazide—type 2 diabetes mellitus	0.000336	0.00103	CcSEcCtD
Didanosine—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000336	0.00103	CcSEcCtD
Didanosine—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000336	0.00103	CcSEcCtD
Didanosine—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000335	0.00103	CcSEcCtD
Didanosine—PNP—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000335	0.00341	CbGpPWpGaD
Didanosine—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000335	0.00103	CcSEcCtD
Didanosine—Nausea—Repaglinide—type 2 diabetes mellitus	0.000335	0.00103	CcSEcCtD
Didanosine—Asthenia—Glipizide—type 2 diabetes mellitus	0.000334	0.00103	CcSEcCtD
Didanosine—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000333	0.00102	CcSEcCtD
Didanosine—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000332	0.00102	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.000332	0.00337	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000331	0.00336	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000331	0.00336	CbGpPWpGaD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.00033	0.00336	CbGpPWpGaD
Didanosine—Pruritus—Glipizide—type 2 diabetes mellitus	0.00033	0.00101	CcSEcCtD
Didanosine—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000329	0.00101	CcSEcCtD
Didanosine—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000329	0.00101	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000327	0.001	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000326	0.00332	CbGpPWpGaD
Didanosine—Flatulence—Metformin—type 2 diabetes mellitus	0.000325	0.000999	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000325	0.0033	CbGpPWpGaD
Didanosine—Malaise—Orlistat—type 2 diabetes mellitus	0.000323	0.000992	CcSEcCtD
Didanosine—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000322	0.000989	CcSEcCtD
Didanosine—Chills—Irbesartan—type 2 diabetes mellitus	0.000321	0.000986	CcSEcCtD
Didanosine—Gastrointestinal pain—Bromocriptine—type 2 diabetes mellitus	0.000321	0.000985	CcSEcCtD
Didanosine—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.00032	0.000984	CcSEcCtD
Didanosine—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.00032	0.000984	CcSEcCtD
Didanosine—Infection—Gliclazide—type 2 diabetes mellitus	0.00032	0.000983	CcSEcCtD
Didanosine—PNP—Metabolism—HSD17B3—type 2 diabetes mellitus	0.00032	0.00325	CbGpPWpGaD
Didanosine—PNP—Metabolism—STAR—type 2 diabetes mellitus	0.00032	0.00325	CbGpPWpGaD
Didanosine—PNP—Metabolism—ACACA—type 2 diabetes mellitus	0.00032	0.00325	CbGpPWpGaD
Didanosine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000319	0.000981	CcSEcCtD
Didanosine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000319	0.000979	CcSEcCtD
Didanosine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000316	0.000971	CcSEcCtD
Didanosine—Dyspepsia—Glyburide—type 2 diabetes mellitus	0.000316	0.00097	CcSEcCtD
Didanosine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000315	0.000969	CcSEcCtD
Didanosine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000315	0.000969	CcSEcCtD
Didanosine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000312	0.000958	CcSEcCtD
Didanosine—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000312	0.000958	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000312	0.00317	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000312	0.00317	CbGpPWpGaD
Didanosine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000311	0.000955	CcSEcCtD
Didanosine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.00031	0.000953	CcSEcCtD
Didanosine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.00031	0.000953	CcSEcCtD
Didanosine—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000309	0.000948	CcSEcCtD
Didanosine—Myalgia—Valsartan—type 2 diabetes mellitus	0.000309	0.000948	CcSEcCtD
Didanosine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000308	0.000945	CcSEcCtD
Didanosine—Flatulence—Irbesartan—type 2 diabetes mellitus	0.000307	0.000943	CcSEcCtD
Didanosine—PNP—Metabolism—ABCC8—type 2 diabetes mellitus	0.000307	0.00312	CbGpPWpGaD
Didanosine—PNP—Metabolism—CBS—type 2 diabetes mellitus	0.000307	0.00312	CbGpPWpGaD
Didanosine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000305	0.000938	CcSEcCtD
Didanosine—Myalgia—Orlistat—type 2 diabetes mellitus	0.000305	0.000937	CcSEcCtD
Didanosine—Hepatobiliary disease—Ramipril—type 2 diabetes mellitus	0.000304	0.000935	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000304	0.00309	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.000302	0.00307	CbGpPWpGaD
Didanosine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000302	0.000927	CcSEcCtD
Didanosine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000301	0.000926	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000301	0.00305	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000301	0.00305	CbGpPWpGaD
Didanosine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.0003	0.000922	CcSEcCtD
Didanosine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000298	0.000916	CcSEcCtD
Didanosine—Malaise—Metformin—type 2 diabetes mellitus	0.000298	0.000915	CcSEcCtD
Didanosine—Alopecia—Losartan—type 2 diabetes mellitus	0.000298	0.000914	CcSEcCtD
Didanosine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000298	0.000914	CcSEcCtD
Didanosine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000297	0.000911	CcSEcCtD
Didanosine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000296	0.00091	CcSEcCtD
Didanosine—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000296	0.000909	CcSEcCtD
Didanosine—PNP—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000295	0.003	CbGpPWpGaD
Didanosine—PNP—Metabolism—COX2—type 2 diabetes mellitus	0.000295	0.003	CbGpPWpGaD
Didanosine—Infection—Valsartan—type 2 diabetes mellitus	0.000294	0.000903	CcSEcCtD
Didanosine—Rash—Glipizide—type 2 diabetes mellitus	0.000294	0.000903	CcSEcCtD
Didanosine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000294	0.000902	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000293	0.000901	CcSEcCtD
Didanosine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000293	0.000901	CcSEcCtD
Didanosine—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000292	0.000898	CcSEcCtD
Didanosine—Headache—Glipizide—type 2 diabetes mellitus	0.000292	0.000897	CcSEcCtD
Didanosine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000291	0.00295	CbGpPWpGaD
Didanosine—Infection—Orlistat—type 2 diabetes mellitus	0.00029	0.000892	CcSEcCtD
Didanosine—PNP—Metabolism—NCOA6—type 2 diabetes mellitus	0.00029	0.00295	CbGpPWpGaD
Didanosine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.00029	0.00089	CcSEcCtD
Didanosine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000289	0.000888	CcSEcCtD
Didanosine—Flatulence—Losartan—type 2 diabetes mellitus	0.000289	0.000888	CcSEcCtD
Didanosine—Hepatitis—Ramipril—type 2 diabetes mellitus	0.000289	0.000887	CcSEcCtD
Didanosine—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000288	0.000885	CcSEcCtD
Didanosine—PNP—Metabolism—UCP3—type 2 diabetes mellitus	0.000285	0.0029	CbGpPWpGaD
Didanosine—PNP—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000285	0.0029	CbGpPWpGaD
Didanosine—PNP—Metabolism—UCP2—type 2 diabetes mellitus	0.000285	0.0029	CbGpPWpGaD
Didanosine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000283	0.000871	CcSEcCtD
Didanosine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	0.000283	0.000871	CcSEcCtD
Didanosine—Anorexia—Valsartan—type 2 diabetes mellitus	0.000282	0.000866	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000281	0.00286	CbGpPWpGaD
Didanosine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.000281	0.000865	CcSEcCtD
Didanosine—Myalgia—Metformin—type 2 diabetes mellitus	0.000281	0.000863	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000281	0.00286	CbGpPWpGaD
Didanosine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000281	0.000863	CcSEcCtD
Didanosine—Headache—Pioglitazone—type 2 diabetes mellitus	0.00028	0.000859	CcSEcCtD
Didanosine—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000279	0.000857	CcSEcCtD
Didanosine—Discomfort—Metformin—type 2 diabetes mellitus	0.000278	0.000853	CcSEcCtD
Didanosine—Nausea—Glipizide—type 2 diabetes mellitus	0.000277	0.00085	CcSEcCtD
Didanosine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000276	0.000849	CcSEcCtD
Didanosine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000276	0.000847	CcSEcCtD
Didanosine—Pain—Gliclazide—type 2 diabetes mellitus	0.000275	0.000846	CcSEcCtD
Didanosine—Rash—Glimepiride—type 2 diabetes mellitus	0.000274	0.000842	CcSEcCtD
Didanosine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000274	0.000842	CcSEcCtD
Didanosine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000273	0.00084	CcSEcCtD
Didanosine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000273	0.000839	CcSEcCtD
Didanosine—Headache—Glimepiride—type 2 diabetes mellitus	0.000272	0.000837	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000272	0.00276	CbGpPWpGaD
Didanosine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000272	0.000834	CcSEcCtD
Didanosine—Anaemia—Losartan—type 2 diabetes mellitus	0.000271	0.000832	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.00027	0.00275	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.00027	0.000828	CcSEcCtD
Didanosine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000268	0.000825	CcSEcCtD
Didanosine—PNP—Metabolism—PCK1—type 2 diabetes mellitus	0.000268	0.00272	CbGpPWpGaD
Didanosine—Infection—Metformin—type 2 diabetes mellitus	0.000268	0.000822	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000266	0.000818	CcSEcCtD
Didanosine—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.000266	0.000816	CcSEcCtD
Didanosine—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000265	0.000815	CcSEcCtD
Didanosine—Myalgia—Irbesartan—type 2 diabetes mellitus	0.000265	0.000815	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000265	0.00269	CbGpPWpGaD
Didanosine—Malaise—Losartan—type 2 diabetes mellitus	0.000264	0.000812	CcSEcCtD
Didanosine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000264	0.000812	CcSEcCtD
Didanosine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000264	0.00081	CcSEcCtD
Didanosine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000263	0.000809	CcSEcCtD
Didanosine—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000263	0.000806	CcSEcCtD
Didanosine—Leukopenia—Losartan—type 2 diabetes mellitus	0.000262	0.000806	CcSEcCtD
Didanosine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000262	0.000805	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000262	0.00266	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000261	0.00265	CbGpPWpGaD
Didanosine—Dyspepsia—Valsartan—type 2 diabetes mellitus	0.00026	0.0008	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.00026	0.00265	CbGpPWpGaD
Didanosine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000259	0.000797	CcSEcCtD
Didanosine—Nausea—Glimepiride—type 2 diabetes mellitus	0.000258	0.000793	CcSEcCtD
Didanosine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000257	0.000791	CcSEcCtD
Didanosine—Dyspepsia—Orlistat—type 2 diabetes mellitus	0.000257	0.000791	CcSEcCtD
Didanosine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000257	0.00079	CcSEcCtD
Didanosine—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000257	0.00079	CcSEcCtD
Didanosine—Anorexia—Metformin—type 2 diabetes mellitus	0.000257	0.000789	CcSEcCtD
Didanosine—Alopecia—Ramipril—type 2 diabetes mellitus	0.000255	0.000784	CcSEcCtD
Didanosine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000255	0.000782	CcSEcCtD
Didanosine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000255	0.000782	CcSEcCtD
Didanosine—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000254	0.000781	CcSEcCtD
Didanosine—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000254	0.000781	CcSEcCtD
Didanosine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000254	0.000779	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000253	0.00257	CbGpPWpGaD
Didanosine—Infection—Irbesartan—type 2 diabetes mellitus	0.000253	0.000776	CcSEcCtD
Didanosine—PNP—Metabolism—HK1—type 2 diabetes mellitus	0.000251	0.00255	CbGpPWpGaD
Didanosine—Pain—Orlistat—type 2 diabetes mellitus	0.00025	0.000768	CcSEcCtD
Didanosine—Arthralgia—Losartan—type 2 diabetes mellitus	0.00025	0.000767	CcSEcCtD
Didanosine—Myalgia—Losartan—type 2 diabetes mellitus	0.00025	0.000767	CcSEcCtD
Didanosine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000249	0.000766	CcSEcCtD
Didanosine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000249	0.000765	CcSEcCtD
Didanosine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000247	0.00076	CcSEcCtD
Didanosine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000247	0.000759	CcSEcCtD
Didanosine—Discomfort—Losartan—type 2 diabetes mellitus	0.000247	0.000758	CcSEcCtD
Didanosine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000246	0.000755	CcSEcCtD
Didanosine—SLC29A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.000246	0.0025	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000245	0.000754	CcSEcCtD
Didanosine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000245	0.000754	CcSEcCtD
Didanosine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000244	0.00075	CcSEcCtD
Didanosine—PNP—Metabolism—LPA—type 2 diabetes mellitus	0.000242	0.00246	CbGpPWpGaD
Didanosine—PNP—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000242	0.00246	CbGpPWpGaD
Didanosine—PNP—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000242	0.00246	CbGpPWpGaD
Didanosine—PNP—Metabolism—GCKR—type 2 diabetes mellitus	0.000242	0.00246	CbGpPWpGaD
Didanosine—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000242	0.000745	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000242	0.00246	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000242	0.000743	CcSEcCtD
Didanosine—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000242	0.000743	CcSEcCtD
Didanosine—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000239	0.000735	CcSEcCtD
Didanosine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000239	0.000734	CcSEcCtD
Didanosine—Infection—Losartan—type 2 diabetes mellitus	0.000238	0.00073	CcSEcCtD
Didanosine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000237	0.000729	CcSEcCtD
Didanosine—Dyspepsia—Metformin—type 2 diabetes mellitus	0.000237	0.000729	CcSEcCtD
Didanosine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.000234	0.00072	CcSEcCtD
Didanosine—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000234	0.000719	CcSEcCtD
Didanosine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000234	0.000718	CcSEcCtD
Didanosine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000233	0.000716	CcSEcCtD
Didanosine—PNP—Metabolism—ALDOB—type 2 diabetes mellitus	0.000232	0.00236	CbGpPWpGaD
Didanosine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000232	0.000712	CcSEcCtD
Didanosine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000231	0.00071	CcSEcCtD
Didanosine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000231	0.00071	CcSEcCtD
Didanosine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000231	0.00071	CcSEcCtD
Didanosine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000228	0.000701	CcSEcCtD
Didanosine—Anorexia—Losartan—type 2 diabetes mellitus	0.000228	0.000701	CcSEcCtD
Didanosine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000228	0.0007	CcSEcCtD
Didanosine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000228	0.0007	CcSEcCtD
Didanosine—Malaise—Ramipril—type 2 diabetes mellitus	0.000227	0.000696	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.000226	0.0023	CbGpPWpGaD
Didanosine—Rash—Glyburide—type 2 diabetes mellitus	0.000226	0.000695	CcSEcCtD
Didanosine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000226	0.000694	CcSEcCtD
Didanosine—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000225	0.000691	CcSEcCtD
Didanosine—Headache—Glyburide—type 2 diabetes mellitus	0.000225	0.00069	CcSEcCtD
Didanosine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	0.000224	0.000688	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000221	0.00225	CbGpPWpGaD
Didanosine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000221	0.000679	CcSEcCtD
Didanosine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.00022	0.000677	CcSEcCtD
Didanosine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.00022	0.000677	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.000218	0.00067	CcSEcCtD
Didanosine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000218	0.00067	CcSEcCtD
Didanosine—Pain—Irbesartan—type 2 diabetes mellitus	0.000217	0.000668	CcSEcCtD
Didanosine—PNP—Metabolism—GLP1R—type 2 diabetes mellitus	0.000216	0.0022	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000216	0.00219	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000216	0.00219	CbGpPWpGaD
Didanosine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000215	0.000662	CcSEcCtD
Didanosine—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000215	0.00066	CcSEcCtD
Didanosine—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000214	0.000657	CcSEcCtD
Didanosine—Myalgia—Ramipril—type 2 diabetes mellitus	0.000214	0.000657	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000214	0.00217	CbGpPWpGaD
Didanosine—Nausea—Glyburide—type 2 diabetes mellitus	0.000213	0.000654	CcSEcCtD
Didanosine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000213	0.000654	CcSEcCtD
Didanosine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000212	0.000652	CcSEcCtD
Didanosine—Discomfort—Ramipril—type 2 diabetes mellitus	0.000211	0.00065	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000211	0.00214	CbGpPWpGaD
Didanosine—Dyspepsia—Losartan—type 2 diabetes mellitus	0.000211	0.000647	CcSEcCtD
Didanosine—Asthenia—Orlistat—type 2 diabetes mellitus	0.00021	0.000644	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.00021	0.00213	CbGpPWpGaD
Didanosine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000209	0.000643	CcSEcCtD
Didanosine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000209	0.000643	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000209	0.00212	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000208	0.00212	CbGpPWpGaD
Didanosine—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000208	0.000639	CcSEcCtD
Didanosine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000208	0.000639	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000208	0.00211	CbGpPWpGaD
Didanosine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000207	0.000635	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000206	0.00209	CbGpPWpGaD
Didanosine—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000205	0.00063	CcSEcCtD
Didanosine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000205	0.000629	CcSEcCtD
Didanosine—Pain—Losartan—type 2 diabetes mellitus	0.000205	0.000629	CcSEcCtD
Didanosine—Rash—Gliclazide—type 2 diabetes mellitus	0.000203	0.000624	CcSEcCtD
Didanosine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000203	0.000623	CcSEcCtD
Didanosine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000202	0.000622	CcSEcCtD
Didanosine—Headache—Gliclazide—type 2 diabetes mellitus	0.000202	0.00062	CcSEcCtD
Didanosine—PNP—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000202	0.00205	CbGpPWpGaD
Didanosine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000201	0.000617	CcSEcCtD
Didanosine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000201	0.000617	CcSEcCtD
Didanosine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000201	0.000617	CcSEcCtD
Didanosine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.0002	0.000614	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000199	0.00202	CbGpPWpGaD
Didanosine—PNP—Metabolism—MTR—type 2 diabetes mellitus	0.000198	0.00201	CbGpPWpGaD
Didanosine—PNP—Metabolism—CPT1A—type 2 diabetes mellitus	0.000198	0.00201	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000196	0.000601	CcSEcCtD
Didanosine—Anorexia—Ramipril—type 2 diabetes mellitus	0.000196	0.000601	CcSEcCtD
Didanosine—PNP—Metabolism—NAMPT—type 2 diabetes mellitus	0.000194	0.00197	CbGpPWpGaD
Didanosine—Asthenia—Metformin—type 2 diabetes mellitus	0.000193	0.000594	CcSEcCtD
Didanosine—PNP—Metabolism—LIPC—type 2 diabetes mellitus	0.000193	0.00196	CbGpPWpGaD
Didanosine—PNP—Metabolism—HBA1—type 2 diabetes mellitus	0.000193	0.00196	CbGpPWpGaD
Didanosine—PNP—Metabolism—GCK—type 2 diabetes mellitus	0.000193	0.00196	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP11A1—type 2 diabetes mellitus	0.000191	0.00194	CbGpPWpGaD
Didanosine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000191	0.000588	CcSEcCtD
Didanosine—Pruritus—Metformin—type 2 diabetes mellitus	0.000191	0.000586	CcSEcCtD
Didanosine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000189	0.000581	CcSEcCtD
Didanosine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000189	0.000581	CcSEcCtD
Didanosine—Vomiting—Valsartan—type 2 diabetes mellitus	0.000188	0.000578	CcSEcCtD
Didanosine—PNP—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000188	0.00191	CbGpPWpGaD
Didanosine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.000187	0.000575	CcSEcCtD
Didanosine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.000187	0.000574	CcSEcCtD
Didanosine—Rash—Valsartan—type 2 diabetes mellitus	0.000187	0.000573	CcSEcCtD
Didanosine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000186	0.000573	CcSEcCtD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000186	0.00189	CbGpPWpGaD
Didanosine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000186	0.000571	CcSEcCtD
Didanosine—PNP—Metabolism—CETP—type 2 diabetes mellitus	0.000186	0.00189	CbGpPWpGaD
Didanosine—Headache—Valsartan—type 2 diabetes mellitus	0.000185	0.000569	CcSEcCtD
Didanosine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000184	0.000566	CcSEcCtD
Didanosine—Rash—Orlistat—type 2 diabetes mellitus	0.000184	0.000566	CcSEcCtD
Didanosine—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000184	0.000566	CcSEcCtD
Didanosine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000184	0.000566	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000184	0.00187	CbGpPWpGaD
Didanosine—Headache—Orlistat—type 2 diabetes mellitus	0.000183	0.000563	CcSEcCtD
Didanosine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000182	0.00056	CcSEcCtD
Didanosine—Dyspepsia—Ramipril—type 2 diabetes mellitus	0.000181	0.000555	CcSEcCtD
Didanosine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.00018	0.000553	CcSEcCtD
Didanosine—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000178	0.000548	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000178	0.00181	CbGpPWpGaD
Didanosine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000176	0.000542	CcSEcCtD
Didanosine—Nausea—Valsartan—type 2 diabetes mellitus	0.000176	0.00054	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.000175	0.00178	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.000175	0.00177	CbGpPWpGaD
Didanosine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000174	0.000534	CcSEcCtD
Didanosine—Nausea—Orlistat—type 2 diabetes mellitus	0.000174	0.000533	CcSEcCtD
Didanosine—PNP—Metabolism—PSMD6—type 2 diabetes mellitus	0.000173	0.00176	CbGpPWpGaD
Didanosine—PNP—Metabolism—SREBF1—type 2 diabetes mellitus	0.000173	0.00176	CbGpPWpGaD
Didanosine—PNP—Metabolism—SNAP25—type 2 diabetes mellitus	0.000173	0.00176	CbGpPWpGaD
Didanosine—Asthenia—Losartan—type 2 diabetes mellitus	0.000172	0.000527	CcSEcCtD
Didanosine—Vomiting—Metformin—type 2 diabetes mellitus	0.000171	0.000526	CcSEcCtD
Didanosine—SLC29A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	0.00017	0.00173	CbGpPWpGaD
Didanosine—Rash—Metformin—type 2 diabetes mellitus	0.00017	0.000522	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	0.00017	0.00173	CbGpPWpGaD
Didanosine—Dermatitis—Metformin—type 2 diabetes mellitus	0.00017	0.000521	CcSEcCtD
Didanosine—PNP—Metabolism—CTGF—type 2 diabetes mellitus	0.00017	0.00172	CbGpPWpGaD
Didanosine—Pruritus—Losartan—type 2 diabetes mellitus	0.000169	0.00052	CcSEcCtD
Didanosine—Headache—Metformin—type 2 diabetes mellitus	0.000169	0.000519	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000169	0.00171	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000169	0.00171	CbGpPWpGaD
Didanosine—PNP—Metabolism—HMGCR—type 2 diabetes mellitus	0.000168	0.00171	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	0.000168	0.00171	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000168	0.00171	CbGpPWpGaD
Didanosine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000168	0.000515	CcSEcCtD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	0.000166	0.00168	CbGpPWpGaD
Didanosine—PNP—Metabolism—ADRA2A—type 2 diabetes mellitus	0.000164	0.00167	CbGpPWpGaD
Didanosine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000164	0.000503	CcSEcCtD
Didanosine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000162	0.000498	CcSEcCtD
Didanosine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000162	0.000498	CcSEcCtD
Didanosine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000162	0.000497	CcSEcCtD
Didanosine—Rash—Irbesartan—type 2 diabetes mellitus	0.00016	0.000492	CcSEcCtD
Didanosine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00016	0.000492	CcSEcCtD
Didanosine—Nausea—Metformin—type 2 diabetes mellitus	0.00016	0.000492	CcSEcCtD
Didanosine—Headache—Irbesartan—type 2 diabetes mellitus	0.000159	0.000489	CcSEcCtD
Didanosine—PNP—Metabolism—CYP2E1—type 2 diabetes mellitus	0.000158	0.00161	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000158	0.0016	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC2A1—type 2 diabetes mellitus	0.000156	0.00159	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP1A2—type 2 diabetes mellitus	0.000156	0.00159	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000154	0.00157	CbGpPWpGaD
Didanosine—PNP—Metabolism—CYP3A4—type 2 diabetes mellitus	0.000152	0.00155	CbGpPWpGaD
Didanosine—Vomiting—Losartan—type 2 diabetes mellitus	0.000152	0.000467	CcSEcCtD
Didanosine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000151	0.000464	CcSEcCtD
Didanosine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000151	0.000464	CcSEcCtD
Didanosine—Rash—Losartan—type 2 diabetes mellitus	0.000151	0.000463	CcSEcCtD
Didanosine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000151	0.000463	CcSEcCtD
Didanosine—Headache—Losartan—type 2 diabetes mellitus	0.00015	0.00046	CcSEcCtD
Didanosine—PNP—Metabolism—GCG—type 2 diabetes mellitus	0.00015	0.00152	CbGpPWpGaD
Didanosine—PNP—Metabolism—SLC2A4—type 2 diabetes mellitus	0.00015	0.00152	CbGpPWpGaD
Didanosine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000147	0.000452	CcSEcCtD
Didanosine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000145	0.000446	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	0.000145	0.00147	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	0.000144	0.00146	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	0.000143	0.00145	CbGpPWpGaD
Didanosine—Nausea—Losartan—type 2 diabetes mellitus	0.000142	0.000437	CcSEcCtD
Didanosine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00014	0.000431	CcSEcCtD
Didanosine—SLC29A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	0.000138	0.0014	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	0.000138	0.0014	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000137	0.0014	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000137	0.0014	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.000132	0.00134	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.000132	0.00134	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	0.000132	0.00134	CbGpPWpGaD
Didanosine—Vomiting—Ramipril—type 2 diabetes mellitus	0.00013	0.000401	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.00013	0.00132	CbGpPWpGaD
Didanosine—Rash—Ramipril—type 2 diabetes mellitus	0.000129	0.000397	CcSEcCtD
Didanosine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.000129	0.000397	CcSEcCtD
Didanosine—PNP—Metabolism—GNB3—type 2 diabetes mellitus	0.000129	0.00131	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPARGC1A—type 2 diabetes mellitus	0.000129	0.00131	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	0.000129	0.00131	CbGpPWpGaD
Didanosine—Headache—Ramipril—type 2 diabetes mellitus	0.000129	0.000395	CcSEcCtD
Didanosine—PNP—Metabolism—HMOX1—type 2 diabetes mellitus	0.000128	0.00131	CbGpPWpGaD
Didanosine—PNP—Metabolism—CAT—type 2 diabetes mellitus	0.000127	0.00129	CbGpPWpGaD
Didanosine—SLC29A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	0.000125	0.00127	CbGpPWpGaD
Didanosine—PNP—Metabolism—APOB—type 2 diabetes mellitus	0.000123	0.00125	CbGpPWpGaD
Didanosine—Nausea—Ramipril—type 2 diabetes mellitus	0.000122	0.000374	CcSEcCtD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.00012	0.00122	CbGpPWpGaD
Didanosine—PNP—Metabolism—GSTM1—type 2 diabetes mellitus	0.00012	0.00122	CbGpPWpGaD
Didanosine—PNP—Metabolism—LPL—type 2 diabetes mellitus	0.000117	0.00119	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	0.000116	0.00118	CbGpPWpGaD
Didanosine—PNP—Metabolism—ADCY5—type 2 diabetes mellitus	0.000115	0.00117	CbGpPWpGaD
Didanosine—PNP—Metabolism—GPX1—type 2 diabetes mellitus	0.000115	0.00116	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000113	0.00114	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	0.000112	0.00114	CbGpPWpGaD
Didanosine—PNP—Metabolism—CD36—type 2 diabetes mellitus	0.000112	0.00113	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPP2CA—type 2 diabetes mellitus	0.00011	0.00112	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	0.000109	0.00111	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000109	0.0011	CbGpPWpGaD
Didanosine—PNP—Metabolism—MTHFR—type 2 diabetes mellitus	0.000106	0.00108	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000104	0.00106	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPARA—type 2 diabetes mellitus	0.000104	0.00105	CbGpPWpGaD
Didanosine—PNP—Metabolism—AGT—type 2 diabetes mellitus	0.000101	0.00102	CbGpPWpGaD
Didanosine—PNP—Metabolism—CALM1—type 2 diabetes mellitus	9.88e-05	0.001	CbGpPWpGaD
Didanosine—PNP—Metabolism—APOE—type 2 diabetes mellitus	9.85e-05	0.001	CbGpPWpGaD
Didanosine—PNP—Metabolism—APOA1—type 2 diabetes mellitus	9.74e-05	0.000989	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	9.04e-05	0.000919	CbGpPWpGaD
Didanosine—SLC29A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	8.65e-05	0.000879	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	8.63e-05	0.000877	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	8.63e-05	0.000877	CbGpPWpGaD
Didanosine—PNP—Metabolism—PPARG—type 2 diabetes mellitus	8.58e-05	0.000872	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	8.42e-05	0.000856	CbGpPWpGaD
Didanosine—PNP—Metabolism—INS—type 2 diabetes mellitus	8.41e-05	0.000855	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	8.38e-05	0.000851	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	8.33e-05	0.000846	CbGpPWpGaD
Didanosine—PNP—Metabolism—ALB—type 2 diabetes mellitus	7.71e-05	0.000784	CbGpPWpGaD
Didanosine—PNP—Metabolism—PIK3R1—type 2 diabetes mellitus	7.38e-05	0.00075	CbGpPWpGaD
Didanosine—PNP—Metabolism—NOS3—type 2 diabetes mellitus	7.38e-05	0.00075	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	7.34e-05	0.000746	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	7e-05	0.000712	CbGpPWpGaD
Didanosine—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	6.8e-05	0.000692	CbGpPWpGaD
Didanosine—PNP—Metabolism—PTGS2—type 2 diabetes mellitus	6.75e-05	0.000686	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	6.71e-05	0.000682	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	5.79e-05	0.000588	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	5.76e-05	0.000585	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	5.71e-05	0.00058	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	5.52e-05	0.000561	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	5.16e-05	0.000524	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	4.65e-05	0.000473	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	4.36e-05	0.000444	CbGpPWpGaD
Didanosine—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	3.46e-05	0.000351	CbGpPWpGaD
Didanosine—PNP—Metabolism—AKT1—type 2 diabetes mellitus	3.39e-05	0.000345	CbGpPWpGaD
